Home / News, Videos & Publications / News / Medical Research /

BGU Researchers Develop Breakthrough COVID Testing Technology

BGU Researchers Develop Breakthrough COVID Testing Technology

February 4, 2021

Medical Research, Research News

The Jerusalem Post — A new single-stage test using a combinatorial pooling method for COVID-19 diagnostic testing that will help prevent the spread of the coronavirus by identifying infected people sooner and at a lower cost was developed by researchers from BGU.

The test, developed in a collaboration between BGU, Soroka University Medical Center, The Open University of Israel (OUI) and Clalit Health Services in Israel, successfully identified all positive patients and asymptomatic carriers in a single round of testing.

“We’re pleased to see how quickly Ben-Gurion University researchers’ lifesaving, breakthrough technology has been implemented into laboratories where testing takes place,” says Doug Seserman, CEO of Americans for Ben-Gurion University. “It’s wonderful to see these innovative tests being widely used in Israel and hope we have it soon in the United States as well.”

This new single-stage diagnostic test will help prevent the spread of the disease by identifying infected people sooner and at a lower cost using significantly fewer tests. While some labs pool samples that combine the RNA from several people as a single sample, they must retest each individual to determine which ones are positive. This new method eliminates the need for the second step.

Prof. Tomer Hertz

“Our method is the only process now available to deliver the level of mass testing that countries are currently aiming for in order to control outbreaks,” says BGU’s Prof. Tomer Hertz, of the Shraga Segal Department of Microbiology, Immunology and Genetics.

Prof Hertz is also the co-founder of Poold Diagnostics, which has been contracted to provide the test at Soroka and at the Clalit HMO central laboratory in Tel Aviv.

“We’ve already successfully tested 40,000 samples in Israel during the first two weeks of clinical operation,” says Prof. Hertz.

The PCR-based diagnostic, a combinatorial pooling algorithm, uses compressed sensing for efficient SARS-CoV-2 testing. It was developed by researchers at BGU, the National Institute for Biotechnology in the Negev (NIBN), The Open University of Israel (OUI), and Soroka.

Prof. Hertz says that introducing the Poold method at Soroka’s lab will quadruple the current capacity of 2,000 samples a day with minimal increase in staffing and virtually no increase in materials required. The Poold Diagnostics team is preparing to provide its technology internationally. It could ultimately be used at schools, airports and major events, as well as in large diagnostic laboratories.

Read more in The Jerusalem Post >>